Greedy Insider · Filing
BBNX · Sell · Hopman Mark
Hopman Mark (Chief Commercial Officer) sold 821 shares of Beta Bionics, Inc. (BBNX) at $20.00, about $16K, on Oct 26, 2026, filed with the SEC on Oct 28, 2026.
Greediness Score 46 · Mixed · high confidence. Describes filing structure, not future returns. Not investment advice.
Primary source: SEC EDGAR · Accession 0002048497-26-000023